Merck's Keytruda helps lung cancer patients live longer in trial

Go back to Merck's Keytruda helps lung cancer patients live longer in trial
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 1,201,117       

Bristol-Myers Squibb (NYSE: BMY) Delayed: 61.97 +2.69 (4.54%)
Previous Close $59.28    52 Week High $77.12 
Open $60.67    52 Week Low $49.03 
Day High $62.25    P/E 40.24 
Day Low $60.39    EPS $1.54 
Volume 2,897,527       

Merck & Co. (NYSE: MRK) Delayed: 150.54 +3.17 (2.15%)
Previous Close $147.37    52 Week High $65.46 
Open $149.70    52 Week Low $47.97 
Day High $152.34    P/E 102.41 
Day Low $149.37    EPS $1.47 
Volume 1,832,684